Metabolic and anthropometric determinants of serum Lp(a) concentrations and Apo(a) polymorphism in a healthy Arab population

International Journal of Obesity

Volumn 23, Issue 8, 1999, Pages 855-862

  Akanji, Abayomi O ^a   Al Shayji, I A R ^b   Kumar, P ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b NONE

Author keywords

Arabs; Coronary heart disease; Hyperlipidaemia; Insulin; Lipoprotein(a); Obesity

Indexed keywords

APOLIPOPROTEIN A; CHOLESTEROL; GLUCOSE; INSULIN; LIPID; LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; URATE;

ADOLESCENT; ADULT; ANTHROPOMETRY; ARAB; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; FEMALE; GENETIC POLYMORPHISM; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; KRINGLE DOMAIN; LIPOPROTEIN BLOOD LEVEL; MALE; METABOLISM; NORMAL HUMAN; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; URIC ACID BLOOD LEVEL;

EID: 0032784623     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800963     Document Type: Article

References (38)

1. Sandkamp M, Funke H, Schulte H, Kohler E, Assman G. Lipoprotein (a) is an independent risk factor for myocardial infarction at a young age. Clin Chem 1990; 36: 20-23.
2. Hiraga T, Kobayashi T, Okubo M, Nakanishi K, Sugimoto T, Ohashi Y, Murase T. Prospective study of lipoprotein (a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes. Diabetes Care 1995; 18: 241-244.
3. Jovicic A, Ivanisevic V, Ivanovic I. Lipoprotein (a) in patients with carotid atherosclerosis and ischaemic cerebrovascular disorders. Atherosclerosis 1993; 98: 59-65.
4. Hoff HF, Beck GJ, Skibinsky CI, Jurgens G, O'Neill J, Kramer J, Lytle B. Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation 1988; 77: 1238-1244.
5. Berg K. A new serum type system in man: the Lp-system. Acta Pathol Microbiol Scand 1963; 59: 369-382.
6. van der Hoek YY, Wittekoek ME, Beisiegel U, Kastelein JJP, Koschinsky ML. The apolipoprotein (a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms. Hum Mol Gen 1993; 2: 361-366.
7. Marques-Vidal P, Sie P, Cambou J-P, Chap H, Perret B. Relationships of plasminogen activator inhgibitor and lipoprotein (a) with insulin, testosterone, 17b-estradiol and testosterone binding globulin in myocardial infarction patients and healthy controls. J Clin Endocrinol Metab 1995; 80: 1794-1798.
8. Inoue K, Nago N, Matsuo H, Goto T, Miyamoto T, Saegusa T, Ishikawa S, Kario K, Nakamura Y, Igarachi M. Serum insulin and lipoprotein(a) concentrations. Diabetes Care 1997; 20: 1242-1250.
9. Angelin B. Therapy for lowering lipoprotein (a) levels. Curr Op Lipidol 1997; 8: 337-341.
10. Scanu AM. Structural and functional polymorphism of lipoprotein (a): biological and clinical implications. Clin Chem 1995; 41: 170-172.
11. Frank S, Durovic S, Kostner GM. The assembly of lipoprotein Lp (a). Eur J Clin Invest 1996; 26: 109-114.
12. Etingin OR, Hajjar DP, Hajjar KA, Harpel PC, Nachman RL. Lipoprotein (a) regulates plasminogen activator inhibitor-I expression in endothelial cells. A potential mechanism for thrombogenesis. J Biol Chem 1991; 266: 2459-2465.
13. Fineberg SE. Whither lipoprotein (a): is this lipid subclass a causative or predictive factor in diabetic macrovascular disease. Diabetes Care 1997; 20: 1225-1227.
14. Akanji AO, Al-Sulaiman A, Kinatamitath P, Safar F, Al-Zaid K, Mojiminiyi OA. Profile of hyperlipidaemic patients in Kuwait: frequency of cardiovascular disease risk factors at presentation and initial response to treatment. J Kuwait Med Ass 1997; 29: 25-33.
15. Akanji AO, Abdullah A, Tahzeeb S. Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor I levels in hyperlipidaemic patients in Kuwait. Eur J Clin invest 1997; 27: 380-386.
16. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative centrifuge. Clin Chem 1972; 18: 499-502.
17. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 1987; 80: 458-465.
18. Marcovina SM, Zhang ZH, Gaur VP, Albers JJ. Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites. Biochem Biophys Res Commun 1993; 191: 1192-1196.
19. Kamboh MI, Ferrell RE, Kottke BA. Expressed hypervariable polymorphism of apolipoprotein (a). Am J Hum Genet 1991; 49: 1063-1074.
20. Min W-K, Lee JO, Kim CH, Song J, Kim JQ. Identification of apo(a) phenotypes in a Korean population using a standardised nomenclature system based on the number of kringle IV repeats. Ann Clin Biochem 1997; 34: 681-687.
21. World Health Organisation. Diet, nutrition and the prevention of chronic diseases. Report of a WHO Study Group. WHO Technical Report Series #790. Geneva: WHO; 1990.
22. Lean MEJ, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. Br Med J 1995; 311: 158-161.
23. Phillips DIW, Clark PM, Hales CN, Osmond C. Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med. 1994; 11: 286-292.
24. SPSS-X. User's Guide. 2nd Ed. New York : McGraw Hill; 1986.
25. Evans RW, Bunker CH, Ukoli FAM, Kuller LH. Lipoprotein (a) distribution in a Nigerian population. Ethnicity Health 1997; 2: 47-58.
26. van den Ende A, van der Hoek YY, Kastelein JJP, Koschinsky ML, Labeur C, Rosseneu M. Lipoprotein (a). Adv Clin Chem 1996; 32: 74-134.
27. Boerwinkle E, Leffert CC, Jingpin L, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentration. J Clin Invest 1992; 90: 52-60.
28. Guyton JR, Dahlen GH, Poutsch W, Kantz JA, Gotto MA. Relationship of plasma lipoprotein (a) levels to race and apolipoprotein B. Arteriosclerosis 1985; 5: 265-272.
29. Heinrich J, Sandkamp M, Kokott R, Schulte H, Assmann G. Relationship of lipoprotein(a) to variables of coagulation and fibrinolysis in a healthy population. Clin Chem 1991; 37: 1950-1954.
30. Kronenberg F, Konig P, Neyer U, Auinger M, Pribasnig A, Lang U, Reitinger J, Pinter G, Ultermann G, Dieplinger H. Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by haemodialysis or continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1995; 6: 110-120.
31. Marcovina SM, Albers JJ, Wijsman E, Zhang Z-H, Chapman NH, Kennedy H. Differences in Lp(a) concentrations and apo(a) polymorphs between black and white Americans. J Lipid Res 1996; 37: 2569-2585.
32. Zavaroni I, Bonini L, Fantuzzi M, Dall'Aglio E, Passeri M, Reaven GM. Hyperinsulinaemia, obesity and syndrome X. J Int Med 1994; 235: 51-56.
33. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
34. Despres J-P, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien P-J. Hyperinsulinaemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334: 952-957.
35. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; 337: 382-386.
36. Lip GYH, Jones AF. Lipoprotein (a) and vascular disease: thrombogenesis and atherogenesis. Q J Med 1995; 88: 529-539.
37. Anonymous. Lipoprotein (a). Lancet 1991; 337: 397-398.
38. Gaw A, Boerwinkle E, Cohen JC, Hobbs HH. Comparative analysis of the apo(a) gene, apo(a) glycoprotein and plasma concentrations of Lp(a) in three different ethnic groups. Evidence for no common 'null' allele at the apo(a) locus. J Clin Invest 1994; 93: 2526-2534.